A collaborative IGNITE Network study shows that a quick, precise genetic test can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients. University of Florida researcher Larisa Cavallari, Pharm.D., presented these findings at the American Heart Association Scientific Sessions on Nov. 15, 2016.
Journal of the American Medical Association – Duke University’s Dr. Geoffrey Ginsburg and University of Florida’s Dr. Julie Johnson discuss the value of and challenges facing the use of pharmacogenomics to improve patient care.
The Gainesville Sun spotlights the history and accomplishments of the UF Health Personalized Medicine Program
The Gainesville Sun – The University of Florida’s Dr. Julie Johnson and Dr. Larisa Cavallari discuss the trail the IGNITE Network’s UF Health Personalized Medicine Program has blazed in the field of precision medicine since its founding.
The Duke Chronicle – Dr. Geoffrey Ginsburg of the Duke Center for Applied Genomics and Precision Medicine explains how aspirin’s mechanism of action may help prevent not just cardiovascular disease, but also colon cancer.
The American Journal of Managed Care – Dr. Mia Levy of the Vanderbilt Ingram Cancer Center describes opportunities for the successful dissemination and use of actionable health data for researchers and clinicians alike.
The New York Times – IGNITE Network’s Dr. Carol Horowitz works to reduce disparities in obesity and diabetes in underserved areas of New York City.
Genetic Engineering & Biotechnology News – Dr. Julie Johnson of the UF Health Personalized Medicine Program illuminates how current and future advancements in pharmacogenomic research can lead to additional improvements in the treatment of cardiovascular disease.
The UF College of Pharmacy and UF Health Personalized Medicine Program are studying the enzyme CYP2D6 to help doctors identify the most effective pain medications for patients like Jeff Cruse, a grandfather whose severe back pain was poorly controlled for years before enrolling in the study.
Breast Cancer News – As one of the prestigious Komen Scholars, Dr. Mia Levy will help guide research and advocacy conducted by the Susan G. Komen Foundation.
American Association of Colleges of Pharmacy recognizes outstanding work of University of Florida’s Julie Johnson
AACP News Release – Dr. Julie Johnson received the 2016 Volwiler Research Achievement Award in recognition of sustained excellence in research and scientific contributions.
Pharmacy Times – The University of Florida (UF) College of Pharmacy and the UF Health Personalized Medicine Program (PMP) recently hosted a Precision Medicine Conference and certificate training program for pharmacists in Orlando, Florida.
Duke Medicine News and Communications – Lead author Lori Orlando, M.D., showcases a Duke University study published in the Journal Genetics in Medicine that exposes both the expected and unexpected benefits of using MeTree, a web-based family health history tool.
Genome – Toni Pollin and her colleagues at the University of Maryland’s Program in Personalized and Genomic Medicine have recently implemented a survey for people diagnosed with diabetes that is designed to find and diagnose people with other forms of diabetes, such as MODY.
National Human Genome Research Institute – Researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. They also found evidence that this methylation signature may be present in many more types of cancer.
IGNITE Network – In the first joint network meeting, investigators discuss findings and strategies for advancing genomic medicine
University of Florida – The expanding role of pharmacogenomics in clinical medicine and education was the focus of the inaugural Precision Medicine Conference
Business Report of Central North Florida – In the weeks and months after a patient gets a heart stent, blood clots can pose a major threat to recovery. Now, University of Florida Health researchers have found that a quick genetic test can tell doctors early on whether a crucial anti-clotting drug will work
National Institutes of Health – A newly created team of experts in precision medicine and large clinical research studies will seek public input from the large and diverse stakeholder community interested in the development of the President’s Precision Medicine Initiative and articulate the vision for building the national participant group for the Initiative.
The IGNITE Network’s quarterly newsletter provides timely information on developments within the network with a specific focus on genomic implementation tools available for clinicians, researchers, health educators and patients.